GYKI 52466

Known as: Benzenamine, 4-(8-methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)-, GYKI-52466 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Ibogaine is a tremorigenic hallucinogen that has been proposed for clinical use in treating addiction. We previously reported… (More)
Is this relevant?
2001
2001
GYKI 52466 [1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine], a non-competitive AMPA [alpha-amino-3-hydroxy-5… (More)
Is this relevant?
2000
2000
R,S-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor up-modulators of the benzamide type ("ampakines… (More)
  • figure 2
  • figure 3
  • figure 5
  • figure 6
  • table 1
Is this relevant?
Highly Cited
1997
Highly Cited
1997
In an earlier study we showed that co-administration of the NMDA-receptor antagonist MK-801 during conditioning sessions blocks… (More)
Is this relevant?
1995
1995
We examined the actions of cyclothiazide, aniracetam, and 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine… (More)
Is this relevant?
1995
1995
The behavioural and neurochemical effects of the N-methyl-D-aspartate (NMDA) antagonist dizocilpine and the α-amino-3-hydroxy-5… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
Highly Cited
1993
Highly Cited
1993
In whole-cell voltage-clamp recordings from cultured rat hippocampal neurons, the 2,3-benzodiazepine GYKI 52466 was a potent… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1993
1993
The effects of the non-NMDA glutamate receptor antagonist GYKI 52466 (2.4 and 4.8 mg/kg, i.p.) on spontaneous locomotor activity… (More)
  • figure 1
  • figure 2
Is this relevant?
1991
1991
The excitatory amino acid antagonists, NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline) and GYKI 52466 (1-(4… (More)
Is this relevant?
1991
1991
A new non-N-methyl-D-aspartate (non-NMDA) glutamate receptor antagonist, GYKI 52466, was tested on L-glutamate (Glu)-, kainate… (More)
Is this relevant?